For more information, including the At-A-Glance and full program, click here.
Where:
Omni Shoreham Hotel
2500 Calvert Street NW
Washington, DC 20008
Avac Event
HVTN Full Group Meeting
Avac Event
Webinar: An Overview of Vaccine Development with Julie Ake of MHRP
Lieutenant Colonel Julie Ake, Principal Deputy Director of the US Military HIV Research Program (MHRP), wraps up our HVAD webinar series by providing an overview of MHRP’s HIV program and helping to connect dots in the HIV vaccine field.
Ake takes us through the landmark RV144 trial, the first HIV vaccine trial to show efficacy, and gives a clear and compelling update on where HIV vaccine research is and where it needs to go to ensure the development of a safe and effective vaccine. She also provides insight into the linkages to HIV treatment and cure research, as well as other vaccine development efforts, illuminating in particular the ways in which HIV vaccine research has informed Ebola and Zika vaccine development.
This was the fifth in our series of HIV Vaccine Awareness Day webinars. For details on the full series, visit avac.org/hvad.
Avac Event
HIV Vaccine Research Update: What’s new and why it matters
Professor Linda-Gail Bekker is the Deputy Director of the Desmond Tutu HIV Centre, Chief Operating Officer at the Desmond Tutu HIV Foundation and Professor of Medicine at the University of Cape Town. She is also President-elect of the International AIDS Society.
Amongst many HIV prevention research activities that she leads, she is the principal investigator of the HVTN 100 vaccine trial, and in this webinar she discussed the latest in HIV vaccine research and the most recent updates on the plan to start a new vaccine efficacy trial later this year.
Listen / View Slides / Watch on YouTube / Watch Flash animation
Avac Event
Harnessing Antibodies for HIV Prevention and Treatment
John Mascola of the NIH Vaccine Research Center spoke about harnessing antibodies for HIV prevention and treatment. The recording includes a question and answer period with webinar participants.
For further background, click here to view his CROI plenary session. And this webinar is part of our post-CROI 2016 webinar series. Click to learn more.
Avac Event
HIV Vaccine Awareness Day 2016 Events
Global
- Two live Twitter chats led by Youth Coalition Against AIDS (GYCA) to connect young people throughout Africa with HIV vaccine researchers and IAVI CEO to discuss HIV vaccine research issues.
- “Know your rights” advocacy workshop, a one-hour online workshop led by ICW and facilitated by KAVI-ICR focusing on HIV vaccine R&D, to be attended by ICW women leaders around the world.
Kenya
- Two-day HIV Research and Development Meeting led by WACI-Health for National Civil Society Leaders from the East and Southern African region; titled “Strengthening CSO Leadership in HIV Prevention Research & Development (R&D) in Eastern and Southern Africa (ESA) Region” the meeting aims to accelerate civil society action on investments and innovation in research on AIDS vaccines and other biomedical prevention.
- Mobilizing event organized by KAVI-ICR, to include a boxing match, a procession led by a band, VCT provision, and speeches and updates on HIV and HIV research.
South Africa
- Community event conducted by Aurum Institute with a football match between Aurum MMC clinic and the Clinical Research Centre, Edutainment, VCT, updates on HIV vaccine R&D, and distribution of IEC materials.
Thailand
- HVAD outreach led by Armed Forces Research Institute of Medical Sciences (AFRIMS), including the history of vaccine development globally and in Thailand, and an update on the P5 research program in Africa and its relation to vaccine trials in Thailand; attended by the mayor of Pattaya.
;
;
Uganda
- Grassroots and district level outreach events for fishing communities and high-risk young women to provide updates on currently available prevention options and the need for continued vaccine research—supported and led by IAVI-UVRI and MRC/UVRI.
- Two television talk shows, one in English and one in Uganda providing updates on Uganda’s role in the global efforts to develop an HIV vaccine—supported by the Vaccine Interest Group.
United States
- San Francisco Bay Area meeting with community members and providers to learn about and discuss current HIV vaccine research.
Avac Event
HIV 2016: HIV and Non-Communicable Diseases — Opportunities and Challenges
Where: The New York Academy of Sciences Conference Center in Manhattan
Presented by: UNAIDS and the Microbiology & Infectious Diseases Discussion Group at the New York Academy of Sciences
Speakers:
- Steven G. Deeks, MD, University of California, San Francisc
- Peter Godfrey-Faussett, BA, MBBS, DTM&H, FRCP (UK), UNAID
- Maureen M. Goodenow, PhD, University of Florida Healt
- James Hakim, MBChB, FRCP, University of Zimbabw
- Mark Harrington, Treatment Action Grou
- Peter Lamptey, MD, DrPH, MPH, FHI36
- Linda Kupfer, PhD, Fogarty International Center, NI
- Luiz Loures, MD, MPH, UNAID
- Wafaa El Sadr, MD, MPH, Mailman School of Public Health, Columbia Universit
- Doug Webb, PhD, HIV, Health and Development Group, UNDP
Avac Event
Vaccines in Vivo: Advances in AIDS Vaccine Research
On May 18, advocates around the world observed HIV Vaccine Awareness Day (HVAD)—an annual commemoration of the need for and commitment to the ongoing search for a vaccine. AVAC convened a webinar—Vaccines in Vivo: Advances in AIDS Vaccine Research—and updated a number of materials, including our “HVAD Toolkit” for those interested in easy-to-digest research updates.
This year brought the launch of long-awaited initiation of clinical trials building on positive results from the RV144 “Thai” trial. This effort is led by the Pox-Protein Public-Private Partnership (P5), including the the HIV Vaccine Trials Network, who joined the webinar to provide a status update of their current vaccine research and development program. We also featured Janssen, part of Johnson & Johnson, to provide an overview of the research program they are moving forward that focuses on a cross-clade vaccine product.
In this webinar we discussed:
- When and where the P5 trials are taking place?
- What questions will be asked in the P5 “licensure track” trials—designed to bring a product to market, and what will the “research” track address? [Click here for AVAC’s explanation of the dual tracks.]
- The pipeline beyond the P5 trials—including the candidate Janssen is developing
- The role for advocates in southern Africa and around the world in terms of keeping AIDS vaccine research on track
Avac Event
Vaccine-O-Licious
Join Project ACHIEVE, Ballroom Throwbacks, Impulse Group NYC, AVAC, and Columbia University Medical Center on Monday, May 18th for the 11th annual Vaccine-O-Licious – #VOL2015 with a special Q&A and Meet and Greet with the cast from Triangle Web Series.
Get your free tickets here
Vaccine-O-Licious is an annual event designed to spread the word about HIV Vaccine Awareness Day.The event brought together a variety of performers uniting through dance and song.Peppermint hosted this exciting evening of entertainment, with a little education too!
Address: Santos Party House, 96 Lafayette St, New York, NY, 10013
Doors Open: 6:30 PM
Special Q&A with the cast of Triangle Web Series at 7 PM
Show Time: 7:30 PM
Avac Event
EATG Webinar 3: Microbicides and Vaccines
This series of three webinars, hosted jointly by EATG and AVAC, was designed to prepare and update EATG members for a special meeting on new developments in prevention that took place from January 23-25 in Brussels.
Avac Event
Breakthroughs and Big Questions: Webinar on AIDS vaccine research in 2014
This webinar, which coincided with observances of HIV Vaccine Awareness Day (May 18th) provided an update on follow-on trials that build on the positive findings from the RV144 Thai trial; what looks hopeful in early clinical and pre-clinical science; and why the field has increasing optimism about finding effective HIV-specific antibodies, the “holy grail” of anti-HIV immune responses. As always, your comments and questions help guide the discussion.
View the full webinar here.